Dioscin Alleviates Cardiac Dysfunction in Acute Myocardial Infarction via Rescuing Mitochondrial Malfunction

Tianyu Shen1, Dayin Lyu2, Mengping Zhang3

  • 1Department of Orthopaedic, Taihe Hospital, Hubei University of Medicine, Shiyan, China.

Insights

Dioscin, a natural compound, protects hearts after myocardial infarction by maintaining mitochondrial function. This treatment alleviates cardiac dysfunction and prevents adverse remodeling, offering a potential therapeutic strategy.

Area of Science:

  • Cardiovascular Research
  • Mitochondrial Biology
  • Pharmacology

Background:

  • Myocardial infarction (MI) is a severe heart condition with high mortality.
  • Current treatments like angiography and stenting have limitations, necessitating novel therapeutic approaches.
  • Mitochondrial dysfunction is a key pathological mechanism in post-MI cardiac damage.

Purpose of the Study:

  • To investigate the cardioprotective effects of dioscin, a natural product, on infarcted hearts.
  • To elucidate the underlying mechanisms of dioscin's action, focusing on mitochondrial maintenance.
  • To evaluate dioscin as a potential therapeutic agent for myocardial infarction.

Main Methods:

  • Induction of myocardial infarction in a relevant model.
  • Administration of dioscin to assess its effects on cardiac function and structure.
  • Mitochondrial function assays, including assessment of Krebs cycle activity and reactive oxygen species (ROS) levels.

Main Results:

  • Dioscin treatment significantly alleviated cardiac dysfunction following myocardial infarction.
  • Dioscin administration prevented adverse cardiac remodeling.
  • Mechanistically, dioscin maintained mitochondrial function by supporting the Krebs cycle and suppressing ROS accumulation.

Conclusions:

  • Dioscin exhibits significant cardioprotective effects against myocardial infarction.
  • Mitochondrial maintenance is a key mechanism by which dioscin exerts its therapeutic benefits.
  • Dioscin represents a promising natural product for the development of new treatments for infarcted hearts.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
777
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
46
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
12.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27